𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

✍ Scribed by E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. Illarramendi; J. Lizón; J. A. Moreno; J. Belón; J. Janáriz; M. de la Puente; T. Checa; J. R. Mel; M. González Barón

Publisher
Springer
Year
2004
Tongue
English
Weight
208 KB
Volume
54
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy in locally adva
Neoadjuvant chemotherapy in locally advanced breast cancer
✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were